The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback